| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |